These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1210 related articles for article (PubMed ID: 33689215)

  • 21. MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1.
    Li G; Li J; Li C; Qi H; Dong P; Zheng J; Yu F
    Cell Physiol Biochem; 2016; 38(4):1544-52. PubMed ID: 27074047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
    Feili X; Wu S; Ye W; Tu J; Lou L
    Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.
    Wang J; Chu ES; Chen HY; Man K; Go MY; Huang XR; Lan HY; Sung JJ; Yu J
    Oncotarget; 2015 Mar; 6(9):7325-38. PubMed ID: 25356754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β.
    Chen X; Zhu S; Chen SY; Wang JN; Sun LJ; Tao SM; Li XF; Li HD; Sun YY; Xu CH; Suo XG; Ji ML; Huang C; Meng XM; Li J
    Int Immunopharmacol; 2022 Sep; 110():109034. PubMed ID: 35834952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of miR‑141 deactivates hepatic stellate cells by targeting the PTEN/AKT/mTOR pathway.
    Liang H; Wang X; Si C; Duan Y; Chen B; Liang H; Yang D
    Int J Mol Med; 2020 Jul; 46(1):406-414. PubMed ID: 32319536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
    Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
    Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
    Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
    Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
    Sun J; Zhang H; Li L; Yu L; Fu L
    Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
    Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
    Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling.
    Xiao Y; Wang J; Chen Y; Zhou K; Wen J; Wang Y; Zhou Y; Pan W; Cai W
    Cell Signal; 2014 May; 26(5):925-32. PubMed ID: 24412919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis.
    Liu Y; Wu H; Zhang F; Yang J; He J
    Biochem Cell Biol; 2021 Jun; 99(3):385-395. PubMed ID: 34077275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOTAIR Epigenetically Modulates PTEN Expression via MicroRNA-29b: A Novel Mechanism in Regulation of Liver Fibrosis.
    Yu F; Chen B; Dong P; Zheng J
    Mol Ther; 2017 Jan; 25(1):205-217. PubMed ID: 28129115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.
    Son G; Hines IN; Lindquist J; Schrum LW; Rippe RA
    Hepatology; 2009 Nov; 50(5):1512-23. PubMed ID: 19790269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway.
    Xue Y; Zhu W; Qiao F; Yang Y; Qiu J; Zou C; Gao Y; Zhang X; Li M; Shang Z; Gao Y; Huang L
    J Ethnopharmacol; 2024 Jul; 329():118169. PubMed ID: 38621463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.